PFE logo

Pfizer (PFE) Cost of goods sold

annual cost of goods sold:

$17.85B-$7.10B(-28.46%)
December 31, 2024

Summary

  • As of today (May 29, 2025), PFE annual cost of goods sold is $17.85 billion, with the most recent change of -$7.10 billion (-28.46%) on December 31, 2024.
  • During the last 3 years, PFE annual cost of goods sold has fallen by -$12.97 billion (-42.08%).
  • PFE annual cost of goods sold is now -48.02% below its all-time high of $34.34 billion, reached on December 31, 2022.

Performance

1-year change

-28.46%

3-year change

-42.08%

5-year change

+121.64%

15-year change

+58.99%

PFE Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.4%
PFE annual cost of goods sold is higher than 98.4% of companies in Healthcare sector

Range

All-time high

$34.34B
PFE annual cost of goods sold is currently -48.02% below its historical high of $34.34 billion

3-year low

$17.85B
PFE annual cost of goods sold is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
PFE previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
PFE next annual earnings announcement has not yet been scheduled

OtherPFEincome statement metrics

Annual total expenses

$48.69B
PFE annual total expenses is $48.69 billion

annual operating expenses

$30.84B
PFE annual total operating expenses is $30.84 billion

annual SGA

$14.73B
PFE annual SGA is $14.73 billion

annual D&A

$7.01B
PFE annual depreciation & amortization is $7.01 billion

quarterly cost of goods sold:

$2.85B-$3.06B(-51.85%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE quarterly cost of goods sold is $2.85 billion, with the most recent change of -$3.06 billion (-51.85%) on March 29, 2025.
  • Over the past year, PFE quarterly cost of goods sold has dropped by -$534.00 million (-15.80%).
  • PFE quarterly cost of goods sold is now -71.50% below its all-time high of $9.98 billion, reached on March 1, 2022.

Performance

3-month change

-51.85%

1-year change

-15.8%

3-year change

-71.5%

5-year change

+46.65%

PFE quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

96.84%
PFE quarterly cost of goods sold is higher than 96.84% of companies in Healthcare sector

Range

All-time high

$9.98B
PFE quarterly cost of goods sold is currently -71.50% below its historical high of $9.98 billion

3-year low

$2.85B
PFE quarterly cost of goods sold is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 29, 2025
PFE previous earnings announcement was published on Mar 29, 2025

Next quarterly earnings report date

Jul 30, 2025
PFE next earnings announcement is scheduled for Jul 30, 2025

OtherPFEincome statement metrics

Quarterly total expenses

$9.29B
PFE quarterly total expenses is $9.29 billion

quarterly operating expenses

$6.45B
PFE quarterly total operating expenses is $6.45 billion

quarterly SGA

$3.03B
PFE quarterly SGA is $3.03 billion

quarterly D&A

$1.62B
PFE quarterly depreciation & amortization is $1.62 billion

TTM cost of goods sold:

$17.32B-$534.00M(-2.99%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE TTM cost of goods sold is $17.32 billion, with the most recent change of -$534.00 million (-2.99%) on March 29, 2025.
  • Over the past year, PFE TTM cost of goods sold has dropped by -$6.13 billion (-26.15%).
  • PFE TTM cost of goods sold is now -54.79% below its all-time high of $38.30 billion, reached on June 1, 2022.

Performance

3-month change

-2.99%

1-year change

-26.15%

3-year change

-52.75%

5-year change

+129.03%

PFE TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

98.26%
PFE TTM cost of goods sold is higher than 98.26% of companies in Healthcare sector

Range

All-time high

$38.30B
PFE TTM cost of goods sold is currently -54.79% below its historical high of $38.30 billion

3-year low

$17.32B
PFE TTM cost of goods sold is currently at its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 29, 2025
PFE previous earnings announcement was published on Mar 29, 2025

Next quarterly earnings report date

Jul 30, 2025
PFE next earnings announcement is scheduled for Jul 30, 2025

OtherPFEincome statement metrics

Annual total expenses

$48.69B
PFE annual total expenses is $48.69 billion

annual operating expenses

$30.84B
PFE annual total operating expenses is $30.84 billion

TTM SGA

$473.97B
PFE TTM SGA is $473.97 billion

TTM D&A

$6.89B
PFE TTM depreciation & amortization is $6.89 billion

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

annual cost of goods sold

$17.85B
PFE annual cost of goods sold is $17.85 billion

annual inventory

$10.85B
PFE annual inventory is $10.85 billion

PFE Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.5%-15.8%-26.1%
3 y3 years-42.1%-71.5%-52.8%
5 y5 years+121.6%+46.6%+129.0%

PFE Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-48.0%at low-71.5%at low-54.8%at low
5 y5-year-48.0%+121.6%-71.5%+55.8%-54.8%+178.6%
alltimeall time-48.0%+1236.2%-71.5%+3096.6%-54.8%+3800.2%

PFE Cost of goods sold History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.85B(-51.9%)
$17.32B(-3.0%)
Dec 2024
$17.85B(-28.5%)
$5.91B(+12.3%)
$17.85B(-8.5%)
Sep 2024
-
$5.26B(+59.5%)
$19.50B(-17.0%)
Jun 2024
-
$3.30B(-2.3%)
$23.51B(+0.3%)
Mar 2024
-
$3.38B(-55.3%)
$23.45B(-6.0%)
Dec 2023
$24.95B(-27.3%)
$7.56B(-18.4%)
$24.95B(-7.7%)
Sep 2023
-
$9.27B(+186.3%)
$27.04B(+13.5%)
Jun 2023
-
$3.24B(-33.7%)
$23.83B(-18.5%)
Mar 2023
-
$4.89B(-49.4%)
$29.25B(-14.8%)
Dec 2022
$34.34B(+11.4%)
$9.65B(+59.1%)
$34.34B(-0.3%)
Sep 2022
-
$6.06B(-29.9%)
$34.43B(-10.1%)
Jun 2022
-
$8.65B(-13.4%)
$38.30B(+4.5%)
Mar 2022
-
$9.98B(+2.5%)
$36.65B(+18.9%)
Dec 2021
$30.82B(+263.3%)
$9.74B(-2.0%)
$30.82B(+29.5%)
Sep 2021
-
$9.93B(+42.0%)
$23.80B(+49.9%)
Jun 2021
-
$7.00B(+68.3%)
$15.87B(+48.3%)
Mar 2021
-
$4.16B(+53.3%)
$10.70B(+26.1%)
Dec 2020
$8.48B(+5.3%)
$2.71B(+35.1%)
$8.48B(+36.5%)
Sep 2020
-
$2.01B(+9.9%)
$6.22B(-8.7%)
Jun 2020
-
$1.83B(-5.9%)
$6.81B(-9.9%)
Mar 2020
-
$1.94B(+337.9%)
$7.56B(-6.1%)
Dec 2019
$8.05B(-10.4%)
$443.00M(-83.0%)
$8.05B(-4.4%)
Sep 2019
-
$2.60B(+1.0%)
$8.43B(-1.1%)
Jun 2019
-
$2.58B(+5.9%)
$8.52B(-3.8%)
Mar 2019
-
$2.43B(+198.9%)
$8.86B(-1.4%)
Dec 2018
$8.99B(-20.0%)
$814.00M(-69.8%)
$8.99B(-21.4%)
Sep 2018
-
$2.69B(-7.6%)
$11.43B(-1.3%)
Jun 2018
-
$2.92B(+13.8%)
$11.58B(+2.3%)
Mar 2018
-
$2.56B(-21.3%)
$11.32B(+0.8%)
Dec 2017
$11.23B(-8.9%)
$3.26B(+14.5%)
$11.23B(+0.4%)
Sep 2017
-
$2.84B(+6.9%)
$11.18B(-2.1%)
Jun 2017
-
$2.66B(+7.8%)
$11.42B(-4.3%)
Mar 2017
-
$2.47B(-23.1%)
$11.94B(-3.1%)
Dec 2016
$12.32B(+27.7%)
$3.21B(+4.1%)
$12.32B(-1.6%)
Sep 2016
-
$3.08B(-2.8%)
$12.52B(+7.4%)
Jun 2016
-
$3.17B(+11.3%)
$11.65B(+9.3%)
Mar 2016
-
$2.85B(-16.4%)
$10.66B(+10.5%)
Dec 2015
$9.65B(+0.7%)
$3.41B(+53.7%)
$9.65B(+7.9%)
Sep 2015
-
$2.22B(+1.8%)
$8.94B(-1.6%)
Jun 2015
-
$2.18B(+18.6%)
$9.09B(-3.0%)
Mar 2015
-
$1.84B(-32.0%)
$9.37B(-2.2%)
Dec 2014
$9.58B(-0.1%)
$2.70B(+14.1%)
$9.58B(-1.0%)
Sep 2014
-
$2.37B(-3.8%)
$9.67B(+0.8%)
Jun 2014
-
$2.46B(+20.4%)
$9.59B(+2.3%)
Mar 2014
-
$2.04B(-26.8%)
$9.37B(-2.3%)
Dec 2013
$9.59B(-2.4%)
$2.79B(+22.2%)
$9.59B(+0.4%)
Sep 2013
-
$2.29B(+2.0%)
$9.54B(-0.2%)
Jun 2013
-
$2.24B(-0.9%)
$9.57B(-1.4%)
Mar 2013
-
$2.26B(-17.8%)
$9.70B(-4.7%)
Dec 2012
$9.82B(-21.4%)
$2.75B(+19.2%)
$10.18B(+7.4%)
Sep 2012
-
$2.31B(-2.8%)
$9.48B(-10.4%)
Jun 2012
-
$2.38B(-13.4%)
$10.58B(-10.1%)
Mar 2012
-
$2.75B(+33.8%)
$11.78B(-7.5%)
Dec 2011
$12.50B(-15.5%)
$2.05B(-39.8%)
$12.72B(-7.7%)
Sep 2011
-
$3.41B(-4.5%)
$13.79B(-2.7%)
Jun 2011
-
$3.57B(-3.3%)
$14.17B(-0.8%)
Mar 2011
-
$3.69B(+18.7%)
$14.28B(-3.4%)
Dec 2010
$14.79B(+66.4%)
$3.11B(-17.9%)
$14.79B(-5.3%)
Sep 2010
-
$3.79B(+2.9%)
$15.61B(+14.7%)
Jun 2010
-
$3.68B(-12.3%)
$13.61B(+16.5%)
Mar 2010
-
$4.20B(+6.8%)
$11.68B(+31.4%)
Dec 2009
$8.89B(+9.6%)
$3.94B(+120.0%)
$8.89B(+33.3%)
Sep 2009
-
$1.79B(+1.9%)
$6.67B(-4.8%)
Jun 2009
-
$1.76B(+24.7%)
$7.00B(-7.1%)
Mar 2009
-
$1.41B(-17.9%)
$7.53B(-7.1%)
Dec 2008
$8.11B(-27.8%)
$1.72B(-19.2%)
$8.11B(-10.1%)
Sep 2008
-
$2.12B(-7.3%)
$9.02B(-21.7%)
Jun 2008
-
$2.29B(+15.3%)
$11.52B(+1.6%)
Mar 2008
-
$1.99B(-24.3%)
$11.34B(+0.9%)
Dec 2007
$11.24B(+47.1%)
$2.63B(-43.2%)
$11.24B(+3.8%)
Sep 2007
-
$4.62B(+119.0%)
$10.83B(+32.5%)
Jun 2007
-
$2.11B(+11.8%)
$8.18B(+4.1%)
Mar 2007
-
$1.89B(-14.9%)
$7.86B(+2.8%)
DateAnnualQuarterlyTTM
Dec 2006
$7.64B(+5.6%)
$2.22B(+13.0%)
$7.64B(+3.2%)
Sep 2006
-
$1.96B(+9.6%)
$7.41B(+5.0%)
Jun 2006
-
$1.79B(+7.1%)
$7.05B(+0.4%)
Mar 2006
-
$1.67B(-15.7%)
$7.03B(-6.9%)
Dec 2005
$7.23B(+13.2%)
$1.98B(+23.0%)
$7.55B(+11.5%)
Sep 2005
-
$1.61B(-8.6%)
$6.77B(-0.4%)
Jun 2005
-
$1.76B(-19.6%)
$6.80B(+0.1%)
Mar 2005
-
$2.19B(+81.7%)
$6.79B(+6.2%)
Dec 2004
$6.39B(-33.4%)
$1.21B(-26.5%)
$6.39B(-24.4%)
Sep 2004
-
$1.64B(-6.4%)
$8.45B(-16.3%)
Jun 2004
-
$1.75B(-2.3%)
$10.10B(-2.2%)
Mar 2004
-
$1.79B(-45.1%)
$10.32B(+7.6%)
Dec 2003
$9.59B(+138.9%)
$3.27B(-0.6%)
$9.60B(+28.3%)
Sep 2003
-
$3.29B(+65.9%)
$7.48B(+43.3%)
Jun 2003
-
$1.98B(+85.9%)
$5.22B(+26.0%)
Mar 2003
-
$1.06B(-7.1%)
$4.14B(+3.1%)
Dec 2002
$4.01B(+5.0%)
$1.15B(+11.8%)
$4.01B(+27.9%)
Sep 2002
-
$1.03B(+13.7%)
$3.14B(-4.6%)
Jun 2002
-
$902.00M(-4.0%)
$3.29B(-7.0%)
Mar 2002
-
$940.00M(+245.6%)
$3.54B(-7.4%)
Dec 2001
$3.82B(-23.6%)
$272.00M(-76.9%)
$3.82B(-22.3%)
Sep 2001
-
$1.18B(+2.3%)
$4.92B(-0.9%)
Jun 2001
-
$1.15B(-6.0%)
$4.96B(-0.6%)
Mar 2001
-
$1.22B(-10.7%)
$5.00B(+4.9%)
Dec 2000
$5.01B(+7.4%)
$1.37B(+12.2%)
$4.76B(+1.6%)
Sep 2000
-
$1.22B(+3.5%)
$4.69B(-4.3%)
Jun 2000
-
$1.18B(+19.0%)
$4.90B(+2.4%)
Mar 2000
-
$992.00M(-23.3%)
$4.78B(+13.7%)
Dec 1999
$4.66B(+10.6%)
$1.29B(-9.5%)
$4.21B(-31.8%)
Sep 1999
-
$1.43B(+34.5%)
$6.17B(+22.5%)
Jun 1999
-
$1.06B(+154.3%)
$5.04B(+16.5%)
Mar 1999
-
$418.00M(-87.2%)
$4.32B(+2.2%)
Dec 1998
$4.21B(+212.7%)
$3.26B(+993.3%)
$4.23B(+203.3%)
Sep 1998
-
$298.00M(-14.9%)
$1.40B(+0.2%)
Jun 1998
-
$350.00M(+7.7%)
$1.39B(-2.1%)
Mar 1998
-
$325.00M(-23.0%)
$1.42B(-6.9%)
Dec 1997
$1.35B(+0.9%)
$422.00M(+43.1%)
$1.53B(+27.9%)
Sep 1997
-
$295.00M(-22.4%)
$1.20B(-9.5%)
Jun 1997
-
$380.00M(-11.8%)
$1.32B(-2.6%)
Mar 1997
-
$431.00M(+384.3%)
$1.35B(+1.4%)
Dec 1996
$1.34B(-25.4%)
$89.00M(-78.8%)
$1.34B(-21.7%)
Sep 1996
-
$420.00M(+1.2%)
$1.71B(-3.2%)
Jun 1996
-
$415.00M(+0.7%)
$1.76B(-5.3%)
Mar 1996
-
$412.00M(-10.4%)
$1.86B(-1.3%)
Dec 1995
$1.79B(+10.1%)
$459.60M(-3.4%)
$1.88B(-0.4%)
Sep 1995
-
$475.60M(-7.3%)
$1.89B(+3.9%)
Jun 1995
-
$512.80M(+17.6%)
$1.82B(+7.0%)
Mar 1995
-
$435.90M(-6.8%)
$1.70B(+4.6%)
Dec 1994
$1.63B(+7.5%)
$467.90M(+15.6%)
$1.63B(+3.8%)
Sep 1994
-
$404.80M(+2.6%)
$1.57B(+2.1%)
Jun 1994
-
$394.40M(+9.2%)
$1.54B(+1.3%)
Mar 1994
-
$361.10M(-11.5%)
$1.52B(-0.0%)
Dec 1993
$1.51B(-14.0%)
$408.10M(+9.5%)
$1.52B(-3.2%)
Sep 1993
-
$372.70M(-0.3%)
$1.57B(-5.0%)
Jun 1993
-
$374.00M(+3.5%)
$1.65B(-3.3%)
Mar 1993
-
$361.30M(-21.0%)
$1.70B(-3.3%)
Dec 1992
$1.76B(-10.0%)
$457.60M(+0.5%)
$1.76B(-5.2%)
Sep 1992
-
$455.10M(+5.9%)
$1.86B(-1.5%)
Jun 1992
-
$429.90M(+2.3%)
$1.89B(-1.4%)
Mar 1992
-
$420.30M(-24.1%)
$1.91B(-2.2%)
Dec 1991
$1.96B(-3.8%)
$553.40M(+14.6%)
$1.96B(-2.2%)
Sep 1991
-
$482.70M(+5.7%)
$2.00B(-1.6%)
Jun 1991
-
$456.50M(-1.6%)
$2.03B(-1.0%)
Mar 1991
-
$463.90M(-22.4%)
$2.05B(+1.0%)
Dec 1990
$2.03B(+9.7%)
$597.90M(+15.9%)
$2.03B(+41.6%)
Sep 1990
-
$515.90M(+8.3%)
$1.44B(+56.1%)
Jun 1990
-
$476.20M(+7.3%)
$920.20M(+107.3%)
Mar 1990
-
$444.00M
$444.00M
Dec 1989
$1.86B(+1.6%)
-
-
Dec 1988
$1.83B(+5.2%)
-
-
Dec 1987
$1.73B(+10.3%)
-
-
Dec 1986
$1.57B(+11.1%)
-
-
Dec 1985
$1.42B(+1.4%)
-
-
Dec 1984
$1.40B
-
-

FAQ

  • What is Pfizer annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Pfizer?
  • What is Pfizer annual cost of goods sold year-on-year change?
  • What is Pfizer quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Pfizer?
  • What is Pfizer quarterly cost of goods sold year-on-year change?
  • What is Pfizer TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Pfizer?
  • What is Pfizer TTM cost of goods sold year-on-year change?

What is Pfizer annual cost of goods sold?

The current annual cost of goods sold of PFE is $17.85B

What is the all time high annual cost of goods sold for Pfizer?

Pfizer all-time high annual cost of goods sold is $34.34B

What is Pfizer annual cost of goods sold year-on-year change?

Over the past year, PFE annual cost of goods sold has changed by -$7.10B (-28.46%)

What is Pfizer quarterly cost of goods sold?

The current quarterly cost of goods sold of PFE is $2.85B

What is the all time high quarterly cost of goods sold for Pfizer?

Pfizer all-time high quarterly cost of goods sold is $9.98B

What is Pfizer quarterly cost of goods sold year-on-year change?

Over the past year, PFE quarterly cost of goods sold has changed by -$534.00M (-15.80%)

What is Pfizer TTM cost of goods sold?

The current TTM cost of goods sold of PFE is $17.32B

What is the all time high TTM cost of goods sold for Pfizer?

Pfizer all-time high TTM cost of goods sold is $38.30B

What is Pfizer TTM cost of goods sold year-on-year change?

Over the past year, PFE TTM cost of goods sold has changed by -$6.13B (-26.15%)
On this page